SBT-100 is a human monoclonal antibody (mAb) that targets STAT3. It inhibits IL-6-mediated nuclear translocation of P-STAT3 in HEp-2 and PANC-1 cells and demonstrates tumor growth inhibition in MDA-MB-231.
Target:
STAT
* VAT and and shipping costs not included. Errors and price changes excepted
